CYT007-TNFQb
CYT007-TNFQb Uses, Dosage, Side Effects, Food Interaction and all others data.
CYT007-TNFQb is an active immunization therapy that aims atproviding a novel treatment to people suffering from RA or psoriasis. The vaccine should allow for administration of lowamounts of drug to individual patients (in the microgram range) and for convenient dosing schedules.
| Trade Name | CYT007-TNFQb |
| Generic | CYT007-TNFQb |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in psoriasis and psoriatic disorders.
How CYT007-TNFQb works
CYT007-TNFQb is designed to instruct the patient’s immune system to produce an anti-TNF-α antibody response. The induced antibodies aim to bind and neutrolize soluble TNF-α in order to inhibit its inflammatory activity. That way, the subsequent inflammatory process should be slowed down and the deterioration of skin or other tissues reduced.
Innovators Monograph
You find simplified version here CYT007-TNFQb
